What is the best time in a day to give dose of clexane
Reading File
Finding Sources
Finding Sources
Finding Sources
Searching PubMed
enoxaparin dosing timing once daily twice daily
Reading File
Reading File
There is no single universally "best" time of day to give Clexane (enoxaparin) — the optimal timing depends on the indication and dosing regimen prescribed. Here is a structured breakdown:
Clexane (Enoxaparin) — Dosing Timing
1. Once-Daily Regimen (1.5 mg/kg SC)
- Given at the same time each day — most clinicians prefer evening (e.g., 6–10 pm), particularly for surgical patients, because:
- It allows the peak anti-Xa effect (~3–5 hours post-dose) to pass before morning procedures or mobilisation.
- It aligns with hospital medication rounds.
- There is no pharmacological reason to prefer morning vs evening; consistency is what matters most.
2. Twice-Daily Regimen (1 mg/kg SC every 12 hours)
- Given every 12 hours, e.g., 8 am and 8 pm, or 10 am and 10 pm.
- The spacing of doses matters more than the absolute time — maintain as close to 12-hour intervals as possible.
3. Prophylactic Dose (e.g., 40 mg SC once daily)
- Commonly given in the evening in surgical/medical wards.
- For post-surgical patients, guidelines often recommend giving the first dose 12 hours before or 12 hours after surgery to balance VTE prevention with bleeding risk.
Key Practical Considerations
| Factor | Guidance |
|---|---|
| Consistency | Give at the same time(s) each day |
| Renal impairment (CrCl <30 mL/min) | Dose reduction required; once-daily preferred |
| Peri-procedural/surgery | Time dose to avoid peak effect at time of surgery |
| Pregnancy | Twice-daily dosing often preferred (altered pharmacokinetics) |
| Anti-Xa monitoring | Sample 4 hours after dose if monitoring required |
Summary
- Once-daily: Give at the same time each day — evening is common practice.
- Twice-daily: Every 12 hours, e.g., morning and evening.
- There is no pharmacological superiority of morning vs evening — regularity and correct interval are the critical factors.
Sources: Goldman-Cecil Medicine Table 68-7; Goodman & Gilman's Pharmacological Basis of Therapeutics — Low-Molecular-Weight Heparin
This is a shared conversation. Sign in to Orris to start your own chat.